Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from ...

Vicebio Ltd, a biopharmaceutical company developing novel vaccines, has entered an exclusive, definitive agreement to be ...

AstraZeneca has announced a $50 billion investment in the United States by 2030, creating tens of thousands of new, highly ...

Solvias' Center of Excellence for biologics and novel modalities in Research Triangle Park, North Carolina, is now cGMP ready ...

Jeff Sheehan, Managing Partner at Trinity Capital, Spark’s developer, commented, “Coriolis Pharma’s decision to establish ...

Abzena, an end-to-end integrated CDMO and CRO, has appointed Geoffrey M. Glass as Chief Executive Officer (CEO), effective ...